Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Cash Flow-to-Debt Ratio
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A cash flow-to-debt ratio. Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Cash Flow-to-Debt Ratio of 0.16x as of September 2025, meaning its operating cash flow of CN¥109.83 Million could theoretically repay 0% of its total liabilities (CN¥676.78 Million) in one year. Check Shanghai Shenqi Pharmaceutical Investmen (600613) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)
Cash flow-to-debt ratio of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1998 to 2025. Historical debt coverage capacity for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A across 28 annual periods. Check how aggressively does Shanghai Shenqi Pharmaceutical Investmen reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Cash Flow-to-Debt Ratio by Year (1998–2025)
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A. For the full cash flow conversion analysis, see 600613 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥124.47 Million | CN¥747.59 Million | ▼ -44.8% |
| 2024 | 0.30x | CN¥207.79 Million | CN¥689.01 Million | ▲ +24.3% |
| 2023 | 0.24x | CN¥215.59 Million | CN¥888.77 Million | ▼ -23.4% |
| 2022 | 0.32x | CN¥319.23 Million | CN¥1.01 Billion | ▲ +30.0% |
| 2021 | 0.24x | CN¥184.26 Million | CN¥756.45 Million | ▲ +89.3% |
| 2020 | 0.13x | CN¥99.10 Million | CN¥770.28 Million | ▼ -10.3% |
| 2019 | 0.14x | CN¥128.28 Million | CN¥894.60 Million | ▼ -49.0% |
| 2018 | 0.28x | CN¥148.53 Million | CN¥527.74 Million | ▲ +137.5% |
| 2017 | 0.12x | CN¥66.99 Million | CN¥565.34 Million | ▲ +11689.9% |
| 2016 | 0.00x | CN¥570.41K | CN¥567.56 Million | ▼ -98.7% |
| 2015 | 0.08x | CN¥30.12 Million | CN¥384.98 Million | ▲ +332.0% |
| 2014 | -0.03x | CN¥-8.62 Million | CN¥255.60 Million | ▼ -108.3% |
| 2013 | 0.41x | CN¥74.75 Million | CN¥183.42 Million | ▲ +188.6% |
| 2012 | -0.46x | CN¥-11.18 Million | CN¥24.31 Million | ▼ -336.3% |
| 2011 | -0.11x | CN¥-3.33 Million | CN¥31.57 Million | ▼ -109.1% |
| 2010 | 1.16x | CN¥33.04 Million | CN¥28.48 Million | ▲ +814.1% |
| 2009 | 0.13x | CN¥7.69 Million | CN¥60.61 Million | ▼ -73.4% |
| 2008 | 0.48x | CN¥25.26 Million | CN¥53.04 Million | ▲ +168.5% |
| 2007 | 0.18x | CN¥16.01 Million | CN¥90.23 Million | ▲ +408.6% |
| 2006 | -0.06x | CN¥-6.05 Million | CN¥105.19 Million | ▼ -119.3% |
| 2005 | 0.30x | CN¥32.72 Million | CN¥109.67 Million | ▲ +1012.5% |
| 2004 | 0.03x | CN¥4.96 Million | CN¥184.98 Million | ▼ -16.9% |
| 2003 | 0.03x | CN¥4.52 Million | CN¥139.96 Million | ▼ -71.1% |
| 2002 | 0.11x | CN¥16.02 Million | CN¥143.38 Million | ▲ +185.6% |
| 2001 | -0.13x | CN¥-20.51 Million | CN¥157.14 Million | ▼ -182.1% |
| 2000 | 0.16x | CN¥26.85 Million | CN¥168.97 Million | ▲ +824.8% |
| 1999 | -0.02x | CN¥-3.28 Million | CN¥149.46 Million | ▼ -111.6% |
| 1998 | 0.19x | CN¥72.67 Million | CN¥384.28 Million | — |